RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 144 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,085,514 | +17.9% | 664,773 | +15.1% | 0.00% | 0.0% |
| Q2 2023 | $4,313,515 | +20.9% | 577,445 | +7.9% | 0.00% | 0.0% |
| Q1 2023 | $3,569,297 | -20.6% | 535,127 | -8.2% | 0.00% | 0.0% |
| Q4 2022 | $4,494,945 | +18.0% | 583,002 | +62.8% | 0.00% | 0.0% |
| Q3 2022 | $3,809,000 | +138.7% | 358,066 | +82.6% | 0.00% | – |
| Q2 2022 | $1,596,000 | +6.5% | 196,067 | -6.4% | 0.00% | – |
| Q1 2022 | $1,499,000 | -29.2% | 209,409 | +69.4% | 0.00% | – |
| Q4 2021 | $2,117,000 | +393.5% | 123,586 | +562.1% | 0.00% | – |
| Q3 2021 | $429,000 | +6.7% | 18,667 | +69.5% | 0.00% | – |
| Q2 2021 | $402,000 | – | 11,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $77,730,340 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $44,380,166 | 32.86% |
| MV Management XI, L.L.C. | 1,971,908 | $14,730,153 | 25.77% |
| MIC Capital Management UK LLP | 8,451,758 | $63,134,635 | 12.84% |
| Yong Rong (HK) Asset Management Ltd | 1,174,200 | $8,772 | 3.85% |
| ArchPoint Investors | 1,114,626 | $8,326,256 | 3.22% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,711,148 | $20,252,276 | 0.70% |
| HARVARD MANAGEMENT CO INC | 882,129 | $6,590 | 0.65% |
| Diametric Capital, LP | 119,906 | $895,698 | 0.40% |
| Lingotto Investment Management LLP | 775,077 | $5,789,825 | 0.37% |